Close
![](https://www.domaintherapeutics.com/wp-content/uploads/2022/05/2020-06-30-300x130.png)
ADMARE BIOINNOVATIONS
![](https://www.domaintherapeutics.com/wp-content/uploads/2022/05/2020-06-30-300x130.png)
With a wealth of scientific discovery, Canada is primed to be a global leader in life sciences.
To realize this potential, adMare uses its scientific and commercial expertise, specialized R&D infrastructure, and investment capital to build investable companies, robust ecosystems and industry-ready talent – and re-invests its returns back into the Canadian industry to ensure it is sustained for the long-term.
In 2022, adMare BioInnovations gave its support to Domain Therapeutics and invested in the group to support its advancement to the clinic stage.